Ubs Group Ag Meridian Bioscience Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$31.15 - $33.39 $643,932 - $690,238
20,672 Added 68.75%
50,739 $1.69 Million
Q3 2022

Nov 10, 2022
BUY
$30.9 - $33.55 $712,523 - $773,629
23,059 Added 329.04%
30,067 $948,000
Q2 2022

Aug 10, 2022
SELL
$23.75 - $31.69 $5.15 Million - $6.87 Million
-216,759 Reduced 96.87%
7,008 $213,000
Q1 2022

May 16, 2022
SELL
$19.97 - $26.94 $69,515 - $93,778
-3,481 Reduced 1.53%
223,767 $5.81 Million
Q4 2021

Feb 14, 2022
BUY
$17.46 - $21.61 $3.86 Million - $4.77 Million
220,942 Added 3503.68%
227,248 $4.64 Million
Q3 2021

Nov 15, 2021
SELL
$17.35 - $22.5 $29,633 - $38,430
-1,708 Reduced 21.31%
6,306 $122,000
Q2 2021

Aug 13, 2021
SELL
$18.01 - $28.32 $486,954 - $765,716
-27,038 Reduced 77.14%
8,014 $178,000
Q1 2021

May 12, 2021
BUY
$19.76 - $29.89 $27,189 - $41,128
1,376 Added 4.09%
35,052 $920,000
Q4 2020

Feb 11, 2021
BUY
$15.73 - $21.66 $75,032 - $103,318
4,770 Added 16.5%
33,676 $630,000
Q3 2020

Nov 12, 2020
SELL
$13.54 - $26.41 $49,908 - $97,347
-3,686 Reduced 11.31%
28,906 $491,000
Q2 2020

Jul 31, 2020
SELL
$7.84 - $23.29 $7,722 - $22,940
-985 Reduced 2.93%
32,592 $759,000
Q1 2020

May 01, 2020
SELL
$5.57 - $11.5 $130,276 - $268,973
-23,389 Reduced 41.06%
33,577 $282,000
Q4 2019

Feb 14, 2020
BUY
$7.9 - $10.14 $145,739 - $187,062
18,448 Added 47.89%
56,966 $556,000
Q3 2019

Nov 14, 2019
BUY
$9.17 - $12.01 $198,805 - $260,376
21,680 Added 128.76%
38,518 $365,000
Q2 2019

Aug 14, 2019
BUY
$10.88 - $17.6 $100,672 - $162,852
9,253 Added 121.99%
16,838 $200,000
Q1 2019

May 14, 2019
SELL
$15.51 - $17.61 $251,355 - $285,387
-16,206 Reduced 68.12%
7,585 $134,000
Q4 2018

Feb 14, 2019
BUY
$14.52 - $19.72 $66,022 - $89,666
4,547 Added 23.63%
23,791 $413,000
Q3 2018

Nov 14, 2018
BUY
$14.85 - $16.35 $86,679 - $95,434
5,837 Added 43.54%
19,244 $287,000
Q2 2018

Aug 14, 2018
BUY
$13.8 - $16.8 $57,711 - $70,257
4,182 Added 45.33%
13,407 $213,000
Q1 2018

May 15, 2018
SELL
$13.8 - $16.2 $40,116 - $47,093
-2,907 Reduced 23.96%
9,225 $131,000
Q4 2017

Feb 14, 2018
SELL
$13.55 - $15.8 $60,880 - $70,989
-4,493 Reduced 27.03%
12,132 $170,000
Q3 2017

Nov 14, 2017
SELL
$13.45 - $14.35 $6.42 Million - $6.85 Million
-477,119 Reduced 96.63%
16,625 $238,000
Q2 2017

Aug 14, 2017
BUY
N/A
476,845 Added 2821.74%
493,744 $7.78 Million
Q1 2017

Nov 14, 2017
BUY
N/A
16,899
16,899 $233,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email